5/4/2021
The much-anticipated DTaP-IPV-Hib-HepB vaccine, Vaxelis will begin shipping in June. Not only will this new combination vaccine reduce injections for infants, it may simultaneously be more convenient for healthcare providers. Vaxelis requires no reconstitution and is packaged as a pre-filled syringe. Merck & Sanofi Pasteur’s collaborative effort in making Vaxelis finally available, are ushering in a new era of infant immunization. Medical practices interested in accessing the performance pricing for Vaxelis may do so by returning the participation form.